Epidemiology, diagnosis and management of extra-pulmonary tuberculosis in a low-prevalence country: A four year retrospective study in an Australian Tertiary Infectious Diseases Unit

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Pollett, Simon ^a   Banner, Pamela ^b   O'Sullivan, Matthew V N ^a,c   Ralph, Anna P ^a,d,e  

^a University of Sydney   (Australia)

^b NSW Tuberculosis Program   (Australia)

^c Centre for Infectious Diseases and Microbiology   (Australia)

^d MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^e ROYAL DARWIN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; AUSTRALIA; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG RESPONSE; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL SERVICE; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PRACTICE GUIDELINE; PREVALENCE; RETROSPECTIVE STUDY; AGED; MIDDLE AGED; TERTIARY CARE CENTER; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; AUSTRALIA; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; TERTIARY CARE CENTERS; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84962579607     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0149372     Document Type: Article

References (49)

1. National Tuberculosis Advisory Committee of Communicable Diseases. (2012) The strategic plan for control of tuberculosis in Australia: 2011-2015. Commun Dis Intell Q Rep 36:E286-293. PMID: 23186241
2. Barry C, Waring J, Stapledon R, Konstantinos A (2012) Tuberculosis notifications in Australia, 2008 and 2009. Commun Dis Intell Q Rep 36:82-94. PMID: 23153084
3. Roberts-Witteveen AR, Christensen A, McAnulty JM (2010) EpiReview: tuberculosis in NSW, 2008. N SWPublic Health Bull 21:174-182. doi: 10.1071/NB10005 PMID: 20883656
4. Sandgren A, Hollo V, Van Der Werf MJ (2013) Extrapulmonary tuberculosis in the European Union and European Economic Area, 2002 to 2011. Euro Surveill 18.
5. Peto HM, Pratt RH, Harrington TA, Lo Bue PA, Armstrong LR (2009) Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006. Clin Infect Dis 49:1350-1357. doi: 10.1086/605559 PMID: 19793000
6. Yoon HJ SY, Park WI, Choi JP, Chang KH, Kim JM (2004) Clinical Manifestations and Diagnosis of Extrapulmonary Tuberculosis. Yonsei Medical Journal 45:453-461. PMID: 15227732
7. Tay EL (2013). Innovative use of tuberculosis surveillance data to inform practice & policy. Presented at Advances in Tuberculosis: Australian and Regional Perspectives 14-15 June 2013, Melbourne, Victoria.
8. Porkert MT, Sotir M, Parrott-Moore P, Blumberg HM (1997) Tuberculous meningitis at a large inner-city medical center. Am J Med Sci 313:325-331. PMID: 9186145
9. Marks GB, Christensen A, Sintchenko V, Lowbridge C (2013) Tuberculosis: an old world disease providing new world challenges in NSW. N SWPublic Health Bull 24:22-23. doi: 10.1071/NB13007 PMID: 23849023
10. Available: http://www.wslhd.health.nsw.gov. au. Accessed: 30 September 2013
11. Dobler CC, Marks GB, Simpson SE, Crawford AB (2008) Recurrence of tuberculosis at a Sydney chest clinic between 1994 and 2006: reactivation or reinfection? Med J Aust 188:153-155. PMID: 18241171
12. NSW Health Policy Directive PD2005-071 NHPD.
13. NSW Health Policy Directive PD2008-018 NHPD.
14. Antibiotic Expert Group (2010) Therapeutic guidelines: antibiotic. Version 14. Melbourne: Therapeutic Guidelines Limited; 2010.
15. NSW Health Policy Directive PD2005-071
16. Centers for Disease Control and Prevention (2003) Treatment of tuberculosis. MMWR Recomm Rep 52:1-77.
17. World Health Organization (2009) Treatment of Tuberculosis: guidelines, 4th Edition, 2009.
18. Standardized Method for HPLC Identification of Mycobacteria; 1996 Ed: Steering Committee members of the HPLC Users Group, U. S. Department of Health And Human Services.
19. Available: www.who.int/tb/publications/global-report/2007/table-5/en. Accessed: May 2013
20. Available: www.rcpamanual.edu.au. Accessed: September 2013
21. Kherad O, Herrmann FR, Zellweger JP, Rochat T, Janssens JP (2009) Clinical presentation, demographics and outcome of tuberculosis (TB) in a low incidence area: a 4-year study in Geneva, Switzerland. BMC Infect Dis 9:217. doi: 10.1186/1471-2334-9-217 PMID: 20043847
22. Ducomble T, Tolksdorf K, Karagiannis I, Hauer B, Brodhun B, Haas W, et al. (2013) The burden of extrapulmonary and meningitis tuberculosis: an investigation of national surveillance data, Germany, 2002 to 2009. Euro Surveill 18.
23. Lin JN, Lai CH, Chen YH, Lee SS, Tsai SS, Huang CK, et al. (2009) Risk factors for extra-pulmonary tuberculosis compared to pulmonary tuberculosis. Int J Tuberc Lung Dis 13:620-625. PMID: 19383196
24. Cagatay AA, Caliskan Y, Aksoz S, Gulec L, Kucukoglu S, Cagatay Y, et al. (2004) Extrapulmonary tuberculosis in immunocompetent adults. Scand J Infect Dis 36:799-806. PMID: 15764164
25. Vadwai V, Boehme C, Nabeta P, Shetty A, Alland D, Rodrigues C (2011) Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis? J Clin Microbiol 49:2540-2545. doi: 10.1128/JCM.02319-10 PMID: 21593262
26. Fain O, Lortholary O, Lascaux VV, Amoura II, Babinet P, Beaudreuil J, et al. (2000) Extrapulmonary tuberculosis in the northeastern suburbs of Paris: 141 cases. Eur J Intern Med 11:145-150. PMID: 10854820
27. Cabie A, Matheron S, Vallee E, Coulaud JP (1995) [Tuberculosis in Africans hospitalized in Paris. Impact of infection by the human immunodeficiency virus]. Presse Med 24:601-605. PMID: 7761361
28. Cheng VC, Yew WW, Yuen KY (2005) Molecular diagnostics in tuberculosis. Eur J Clin Microbiol Infect Dis 24:711-720. PMID: 16283213
29. Li Y, Zhang LF, Liu XQ, Wang L, Wang X, Wang J, et al. (2012) The role of in vitro interferongammarelease assay in differentiating intestinal tuberculosis from Crohn's disease in China. J Crohns Colitis 6:317-323. doi: 10.1016/j.crohns.2011.09.002 PMID: 22405168
30. Marais S, Thwaites G, Schoeman JF, Torok ME, Misra UK, Prasad K, et al. (2010) Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis 10:803-812. doi: 10.1016/S1473-3099 (10) 70138-9 PMID: 20822958
31. Jin XJ, Kim JM, Kim HK, Kim L, Choi SJ, Park IS, et al. (2010) Histopathology and TB-PCR kit analysis in differentiating the diagnosis of intestinal tuberculosis and Crohn's disease. World J Gastroenterol 16:2496-2503. PMID: 20503449
32. Lumb R, Bastion I, Carter R, Jelfs P, Keehner T, Sievers A (2011) Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 2008 and 2009. A report of the Australian Mycobacterium Reference Laboratory Network. Commun Dis Intell Q Rep 35:154-161. PMID: 22010508
33. Cho OH, Park KH, Kim SM, Park SJ, Moon SM, Chong YP, et al. (2011) Diagnostic performance of TSPOT. TB for extrapulmonary tuberculosis according to the site of infection. J Infect 63:362-369. doi: 10.1016/j.jinf.2011.06.010 PMID: 21781986
34. Parimon T, Spitters CE, Muangman N, Euathrongchit J, Oren E, Narita M (2008) Unexpected pulmonary involvement in extrapulmonary tuberculosis patients. Chest 134:589-594. doi: 10.1378/chest.08-0319 PMID: 18641092
35. Jover-Diaz F, Cuadrado JM, Matarranz M, Calabuig E (2012) Greater acceptance of routine HIV testing (opt-out) by patients attending an infectious disease unit in Spain. J Int Assoc Physicians AIDS Care (Chic) 11:341-344.
36. Wang JY, Liu CH, Hu FC, Chang HC, Liu JL, Chen JM, et al. (2011) Risk factors of hepatitis during antituberculous treatment and implications of hepatitis virus load. J Infect 62:448-455. doi: 10.1016/j.jinf. 2011.04.005 PMID: 21570123
37. Sievert W, Altraif I, Razavi HA, Abdo A, Ahmed EA, Alomair A, et al. (2011) A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int 31 Suppl 2:61-80. doi: 10.1111/j. 1478-3231.2011.02540.x PMID: 21651703
38. Chien JY, Huang RM, Wang JY, Ruan SY, Chien YJ, Yu CJ, et al. (2010) Hepatitis C virus infection increases hepatitis risk during anti-tuberculosis treatment. Int J Tuberc Lung Dis 14:616-621. PMID: 20392356
39. Volmink J, Garner P (2007) Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev: CD003343. PMID: 17943789
40. Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis. Hong Kong Chest Service/British Medical Research Council. Am Rev Respir Dis 136:1339-1342. PMID: 2891333
41. Khan FA, Minion J, Pai M, Royce S, Burman W, Harries AD, et al. (2010) Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and meta-analysis. Clin Infect Dis 50:1288-1299. doi: 10.1086/651686 PMID: 20353364
42. Mfinanga SG, Kirenga BJ, Chanda DM, Mutayoba B, Mthiyane T, Yimer G, et al. (2014) Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial. Lancet Infect Dis 14:563-571. doi: 10.1016/S1473-3099 (14) 70733-9 PMID: 24810491
43. Havlir DV, Kendall MA, Ive P, Kumwenda J, Swindells S, Qasba SS, et al. (2011) Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med 365:1482-1491. doi: 10.1056/NEJMoa1013607 PMID: 22010914
44. Naidoo K, Baxter C, Abdool Karim SS (2013) When to start antiretroviral therapy during tuberculosis treatment? Curr Opin Infect Dis 26:35-42. doi: 10.1097/QCO.0b013e32835ba8f9 PMID: 23188213
45. Thwaites GE, Nguyen DB, Nguyen HD, Hoang TQ, Do TT, Nguyen TC, et al. (2004) Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 351:1741-1751. PMID: 15496623
46. Strang JI, Kakaza HH, Gibson DG, Allen BW, Mitchison DA, Evans DJ, et al. (1988) Controlled clinical trial of complete open surgical drainage and of prednisolone in treatment of tuberculous pericardial effusion in Transkei. Lancet 2:759-764. PMID: 2901610
47. Mayosi BM, Ntsekhe M, Volmink JA, Commerford PJ (2002) Interventions for treating tuberculous pericarditis. Cochrane Database Syst Rev: CD000526. PMID: 12519546
48. Viswanathan V, Kumpatla S, Aravindalochanan V, Rajan R, Chinnasamy C, Srinivasan R, et al. (2012) Prevalence of diabetes and pre-diabetes and associated risk factors among tuberculosis patients in India. PLoS One 7:e41367. doi: 10.1371/journal.pone.0041367 PMID: 22848473
49. Singanayagam A, Sridhar S, Dhariwal J, Abdel-Aziz D, Munro K, Connell DW, et al. (2012) A comparison between two strategies for monitoring hepatic function during antituberculous therapy. Am J Respir Crit Care Med 185:653-659. doi: 10.1164/rccm.201105-0850OC PMID: 22198973